Cordis US Corp.
cordis.comTotal trials
78
Active
3
Phase 3
21
Total enrollment
87,928
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Coronary Artery Disease36
- Abdominal Aortic Aneurysm4
- Abdominal Aortic Aneurysms3
- Coronary Disease3
- Carotid Artery Disease3
- Angioplasty, Transluminal, Percutaneous Coronary3
- Coronary Arteriosclerosis3
- Arterial Occlusive Diseases3
Frequently asked questions about Cordis US Corp.
- How many clinical trials does Cordis US Corp. have on ClinicalTrials.gov?
- Cordis US Corp. is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Cordis US Corp.'s trials are in Phase 3?
- 21 of Cordis US Corp.'s trials are in Phase 3.
- What therapeutic areas does Cordis US Corp. focus on?
- Cordis US Corp.'s most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysms, Coronary Disease, Carotid Artery Disease.